Genkyotex starts enrolment in Phase II trial of GKT831 to treat PBC

French company Genkyotex has started patient enrolment in a Phase II clinical trial of GKT831 for the treatment of patients with primary biliary cholangitis (PBC).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news